Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5

NCT01944800 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.

NCT NCT01944800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Lead sponsor
Deutsches Herzzentrum Muenchen
Phase
Phase 4
Overall status
Completed
Start date
September 15, 2013
Completion date
September 30, 2021
Enrollment
4,018 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs)